Drug Development News
🇺🇸 FDAFDA breaking news and regulatory updates for BD, investors, and analysts
Showing 1–12 of 21 articles
Biotech’s coming of age: AI, capital efficiency and China reshape the field
Global hematology trials keep research patient-centered and regionally relevant
FDA Issues Final Guidance for Pulmonary Tuberculosis Drug Development
FDLI Annual 2026: Key Regulatory Updates and Industry Trends
FDLI Annual 2026: Key Regulatory Insights & Policy Updates
InflaRx Izicopan Shows Low Reactive Metabolite Formation in Liver Safety Study
InflaRx Reports Favorable Safety Profile for Izicopan in Liver Metabolism Study
Addex Advances Dipraglurant for Brain Injury Recovery, Reports 2025 Financial Results
Viking Therapeutics VK2735 Phase 3 Obesity Trials Fully Enrolled as Company Reports Q1 2026 Results
Sprout Pharmaceuticals Addyi (Flibanserin) Maker Named Top 10 Most Influential Health Company by TIME 2026
Clinical Outsourcing Group Event: Key Takeaways Day 1
FDA Proposes OMUFA User Fee Program for Over-the-Counter Monograph Drugs to Supplement Congressional Funding